Read articles from Global

November 14, 2025 by filtermag.org

Alexis Pleus shared how her son's opioid addiction journey began with a knee injury and prescribed medication, leading to addiction and tragic consequences. She founded Truth Pharm for harm reduction advocacy after losing her sons to overdose. Despite effective community outreach, small organizations like hers lack funding, with major portions going to large hospitals. New York's $3 billion Opioid Settlement Fund mostly supports big institutions, sidelining local groups. The Drug Policy Alliance calls for equitable distribution to combat overdose fatalities, highlighting discriminations faced by those with substance use disorders. Pleus emphasizes the vital role of grassroots groups in filling gaps left by larger systems.

November 14, 2025 by filtermag.org

Alexis Pleus shared how her son's opioid addiction journey began with a knee injury and prescribed medication, leading to addiction and tragic consequences. She founded Truth Pharm for harm reduction advocacy after losing her sons to overdose. Despite effective community outreach, small organizations like hers lack funding, with major portions going to large hospitals. New York's $3 billion Opioid Settlement Fund mostly supports big institutions, sidelining local groups. The Drug Policy Alliance calls for equitable distribution to combat overdose fatalities, highlighting discriminations faced by those with substance use disorders. Pleus emphasizes the vital role of grassroots groups in filling gaps left by larger systems.

November 13, 2025 by vejpkollen.se

Leading scientists criticize the WHO for discouraging smoke-free alternatives like e-cigarettes, snus, and nicotine pouches that can reduce nicotine risks. The organization views harm reduction as a tobacco industry scheme, sparking debate among experts who argue for a more science-based approach. Researchers urge the WHO to engage in open dialogue on smoke-free nicotine products to advance public health goals. Critics note the success of these alternatives in helping smokers quit and reducing harm. The debate highlights the need for evidence-based regulation and a shift towards inclusive discussions to promote a smoke-free society globally.

November 13, 2025 by medicalxpress.com

Experts argue that exposing children to e-cigarettes violates their rights, urging regulations prioritizing children's well-being. With youth e-cigarette use outpacing adults' globally, the World Health Organization stresses that children are more vulnerable to nicotine's harms due to ongoing brain development. Despite legal obligations to protect children under the UN Convention, 62 countries lack e-cigarette regulations. Advocates emphasize the need for stringent regulations to curb youth usage, including sales bans and marketing restrictions. Governments must address enforcement challenges like online marketing to effectively safeguard children's health. Neglecting children's well-being in e-cigarette regulation may have enduring negative repercussions.

November 13, 2025 by sciencedaily.com

Research from the University of Georgia shows that using e-cigarettes, traditional cigarettes, or both increases the risk of developing diabetes. Lead author Sulakshan Neupane highlights the potential health risks associated with e-cigarette use, with vaping alone linked to a 7% increase in prediabetes risk. The study also found that smoking cigarettes or cigars raised prediabetes risk by 15%, with even higher risks for dual users. Factors such as weight, income, and demographics further influenced the likelihood of developing these conditions. Neupane suggests that regular physical activity may help counter some harmful effects. The study emphasizes the need for public health efforts to address smoking and diabetes outcomes.

November 12, 2025 by gfn.tv

As the WHO FCTC COP11 conference approaches, Joanna Junak speaks with tobacco policy expert Clive Bates on GFN News about the growing divide between science and ideology in global tobacco control. Bates warns that prohibitionist approaches risk fueling black markets and ignoring proven harm reduction strategies. Watch now to hear his call for a new evidence-based direction in nicotine and tobacco regulation.

November 12, 2025 by regulatorwatch.com

Article text should be here...As WHO F.C.T.C. delegates meet behind closed doors in Geneva for COP 11, the Taxpayers Protection Alliance is hosting GOOD COP 2.0—the Conference of the People—a public, science-based counter-conference defending tobacco harm reduction and consumer choice. Joining RegWatch is David Williams, TPA President and founder of GOOD COP, who shares the personal story behind his mission, his critique of the WHO’s “phony science,” and his warning that Bloomberg-funded prohibitionism is costing lives.

November 12, 2025 by regulatorwatch.com

As WHO F.C.T.C. delegates meet behind closed doors in Geneva for COP 11, the Taxpayers Protection Alliance is hosting GOOD COP 2.0—the Conference of the People—a public, science-based counter-conference defending tobacco harm reduction and consumer choice. Joining RegWatch is David Williams, TPA President and founder of GOOD COP, who shares the personal story behind his mission, his critique of the WHO’s “phony science,” and his warning that Bloomberg-funded prohibitionism is costing lives.

November 12, 2025 by thepharmacist.co.uk

Teenagers in Scotland are trying unregulated nicotine pouches, experiencing issues like sickness and gum pain, per a study by ScotCen. These pouches, legal since 2019 and available to under-18s, are widely known among pupils as 'snus' or 'upper deckies'. While some believe them safer than smoking or vaping, adverse effects like gum pain and fainting were reported. School staff lack awareness of pouch use. Researchers advocate for stronger regulations and public health messaging. The UK government plans to license vape sellers in England and Wales. Research efforts are ongoing to assess the impact of nicotine products on youth health.

November 11, 2025 by clivebates.com

This page provides statements from independent experts on tobacco science and policy. They are addressed to delegates in advance of the 11th Session of the FCTC Conference of the Parties (COP-11), held in Geneva, 17-22nd November 2025. Each statement is linked from the author’s entry in the table of contents.